Journal of the International Aids Society 2016

2 papers

Top Research Directions

The 5 research directions with Journal of the International Aids Society 2016 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Counterfactual Simulation for Causal Inference150.0%
2Heterologous Prime-Boost Vaccination150.0%
3Linear Mixed Effects Models for Longitudinal Data150.0%
4Parameter Sensitivity Analysis for Complex System Models150.0%
5The Limits of Single Center Clinical Evidence150.0%

Download all directions as CSV

Institutions

Institutions credited by Journal of the International Aids Society 2016 papers: a paper credits every institution named in its affiliations, once. 4 institutions share 2 credited papers.

#InstitutionPapersShare
103jtajd40 150.0%
2Fundação Oswaldo Cruz 150.0%
3Inserm 150.0%
4Université de Bordeaux 150.0%

Download all institutions as CSV

About this data

Papers. Journal of the International Aids Society 2016 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 2 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of the International Aids Society 2016”, https://lacuna.tiptreesystems.com/venue/journal-of-the-international-aids-society/2016.

Top Authors

AuthorPapers
Claudio Jose Struchiner1
Rodolphe Thiébaut1

Papers

Title
Immunologic response in treatment‐naïve HIV‐2‐infected patients: the IeDEA West Africa cohort
Survival benefits of antiretroviral therapy in Brazil: a model‐based analysis